Global Hyaluronidase Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 98

Published Date: 03 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.

According to our (Global Info Research) latest study, the global Hyaluronidase market size was valued at USD 823.8 million in 2022 and is forecast to a readjusted size of USD 1248.1 million by 2029 with a CAGR of 6.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Hyaluronidase market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Hyaluronidase market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (USD/mL), 2018-2029
Global Hyaluronidase market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (USD/mL), 2018-2029
Global Hyaluronidase market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (USD/mL), 2018-2029
Global Hyaluronidase market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (USD/mL), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hyaluronidase
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hyaluronidase market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PrimaPharm, Bausch Health, Amphastar Pharmaceuticals, Halozyme Therapeutics and CooperSurgical Fertility, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Hyaluronidase market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Animal-derived Hyaluronidase
    Synthetic Hyaluronidase

Market segment by Application
    Dermatology
    Plastic Surgery

Major players covered
    PrimaPharm
    Bausch Health
    Amphastar Pharmaceuticals
    Halozyme Therapeutics
    CooperSurgical Fertility
    Shreya Life Sciences
    Sun Pharmaceutical Industries
    CBC Pharma
    STEMCELL Technologies

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyaluronidase product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hyaluronidase, with price, sales, revenue and global market share of Hyaluronidase from 2018 to 2023.
Chapter 3, the Hyaluronidase competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyaluronidase breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hyaluronidase market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hyaluronidase.
Chapter 14 and 15, to describe Hyaluronidase sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Hyaluronidase
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Hyaluronidase Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Animal-derived Hyaluronidase
        1.3.3 Synthetic Hyaluronidase
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Hyaluronidase Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Dermatology
        1.4.3 Plastic Surgery
    1.5 Global Hyaluronidase Market Size & Forecast
        1.5.1 Global Hyaluronidase Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Hyaluronidase Sales Quantity (2018-2029)
        1.5.3 Global Hyaluronidase Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 PrimaPharm
        2.1.1 PrimaPharm Details
        2.1.2 PrimaPharm Major Business
        2.1.3 PrimaPharm Hyaluronidase Product and Services
        2.1.4 PrimaPharm Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 PrimaPharm Recent Developments/Updates
    2.2 Bausch Health
        2.2.1 Bausch Health Details
        2.2.2 Bausch Health Major Business
        2.2.3 Bausch Health Hyaluronidase Product and Services
        2.2.4 Bausch Health Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bausch Health Recent Developments/Updates
    2.3 Amphastar Pharmaceuticals
        2.3.1 Amphastar Pharmaceuticals Details
        2.3.2 Amphastar Pharmaceuticals Major Business
        2.3.3 Amphastar Pharmaceuticals Hyaluronidase Product and Services
        2.3.4 Amphastar Pharmaceuticals Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Amphastar Pharmaceuticals Recent Developments/Updates
    2.4 Halozyme Therapeutics
        2.4.1 Halozyme Therapeutics Details
        2.4.2 Halozyme Therapeutics Major Business
        2.4.3 Halozyme Therapeutics Hyaluronidase Product and Services
        2.4.4 Halozyme Therapeutics Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Halozyme Therapeutics Recent Developments/Updates
    2.5 CooperSurgical Fertility
        2.5.1 CooperSurgical Fertility Details
        2.5.2 CooperSurgical Fertility Major Business
        2.5.3 CooperSurgical Fertility Hyaluronidase Product and Services
        2.5.4 CooperSurgical Fertility Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 CooperSurgical Fertility Recent Developments/Updates
    2.6 Shreya Life Sciences
        2.6.1 Shreya Life Sciences Details
        2.6.2 Shreya Life Sciences Major Business
        2.6.3 Shreya Life Sciences Hyaluronidase Product and Services
        2.6.4 Shreya Life Sciences Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Shreya Life Sciences Recent Developments/Updates
    2.7 Sun Pharmaceutical Industries
        2.7.1 Sun Pharmaceutical Industries Details
        2.7.2 Sun Pharmaceutical Industries Major Business
        2.7.3 Sun Pharmaceutical Industries Hyaluronidase Product and Services
        2.7.4 Sun Pharmaceutical Industries Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
    2.8 CBC Pharma
        2.8.1 CBC Pharma Details
        2.8.2 CBC Pharma Major Business
        2.8.3 CBC Pharma Hyaluronidase Product and Services
        2.8.4 CBC Pharma Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 CBC Pharma Recent Developments/Updates
    2.9 STEMCELL Technologies
        2.9.1 STEMCELL Technologies Details
        2.9.2 STEMCELL Technologies Major Business
        2.9.3 STEMCELL Technologies Hyaluronidase Product and Services
        2.9.4 STEMCELL Technologies Hyaluronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 STEMCELL Technologies Recent Developments/Updates

3 Competitive Environment: Hyaluronidase by Manufacturer
    3.1 Global Hyaluronidase Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Hyaluronidase Revenue by Manufacturer (2018-2023)
    3.3 Global Hyaluronidase Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Hyaluronidase by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Hyaluronidase Manufacturer Market Share in 2022
        3.4.2 Top 6 Hyaluronidase Manufacturer Market Share in 2022
    3.5 Hyaluronidase Market: Overall Company Footprint Analysis
        3.5.1 Hyaluronidase Market: Region Footprint
        3.5.2 Hyaluronidase Market: Company Product Type Footprint
        3.5.3 Hyaluronidase Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Hyaluronidase Market Size by Region
        4.1.1 Global Hyaluronidase Sales Quantity by Region (2018-2029)
        4.1.2 Global Hyaluronidase Consumption Value by Region (2018-2029)
        4.1.3 Global Hyaluronidase Average Price by Region (2018-2029)
    4.2 North America Hyaluronidase Consumption Value (2018-2029)
    4.3 Europe Hyaluronidase Consumption Value (2018-2029)
    4.4 Asia-Pacific Hyaluronidase Consumption Value (2018-2029)
    4.5 South America Hyaluronidase Consumption Value (2018-2029)
    4.6 Middle East and Africa Hyaluronidase Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Hyaluronidase Sales Quantity by Type (2018-2029)
    5.2 Global Hyaluronidase Consumption Value by Type (2018-2029)
    5.3 Global Hyaluronidase Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Hyaluronidase Sales Quantity by Application (2018-2029)
    6.2 Global Hyaluronidase Consumption Value by Application (2018-2029)
    6.3 Global Hyaluronidase Average Price by Application (2018-2029)

7 North America
    7.1 North America Hyaluronidase Sales Quantity by Type (2018-2029)
    7.2 North America Hyaluronidase Sales Quantity by Application (2018-2029)
    7.3 North America Hyaluronidase Market Size by Country
        7.3.1 North America Hyaluronidase Sales Quantity by Country (2018-2029)
        7.3.2 North America Hyaluronidase Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Hyaluronidase Sales Quantity by Type (2018-2029)
    8.2 Europe Hyaluronidase Sales Quantity by Application (2018-2029)
    8.3 Europe Hyaluronidase Market Size by Country
        8.3.1 Europe Hyaluronidase Sales Quantity by Country (2018-2029)
        8.3.2 Europe Hyaluronidase Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Hyaluronidase Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Hyaluronidase Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Hyaluronidase Market Size by Region
        9.3.1 Asia-Pacific Hyaluronidase Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Hyaluronidase Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Hyaluronidase Sales Quantity by Type (2018-2029)
    10.2 South America Hyaluronidase Sales Quantity by Application (2018-2029)
    10.3 South America Hyaluronidase Market Size by Country
        10.3.1 South America Hyaluronidase Sales Quantity by Country (2018-2029)
        10.3.2 South America Hyaluronidase Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Hyaluronidase Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Hyaluronidase Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Hyaluronidase Market Size by Country
        11.3.1 Middle East & Africa Hyaluronidase Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Hyaluronidase Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Hyaluronidase Market Drivers
    12.2 Hyaluronidase Market Restraints
    12.3 Hyaluronidase Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Hyaluronidase and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Hyaluronidase
    13.3 Hyaluronidase Production Process
    13.4 Hyaluronidase Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Hyaluronidase Typical Distributors
    14.3 Hyaluronidase Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Hyaluronidase Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Hyaluronidase Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. PrimaPharm Basic Information, Manufacturing Base and Competitors
    Table 4. PrimaPharm Major Business
    Table 5. PrimaPharm Hyaluronidase Product and Services
    Table 6. PrimaPharm Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. PrimaPharm Recent Developments/Updates
    Table 8. Bausch Health Basic Information, Manufacturing Base and Competitors
    Table 9. Bausch Health Major Business
    Table 10. Bausch Health Hyaluronidase Product and Services
    Table 11. Bausch Health Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Bausch Health Recent Developments/Updates
    Table 13. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 14. Amphastar Pharmaceuticals Major Business
    Table 15. Amphastar Pharmaceuticals Hyaluronidase Product and Services
    Table 16. Amphastar Pharmaceuticals Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Amphastar Pharmaceuticals Recent Developments/Updates
    Table 18. Halozyme Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 19. Halozyme Therapeutics Major Business
    Table 20. Halozyme Therapeutics Hyaluronidase Product and Services
    Table 21. Halozyme Therapeutics Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Halozyme Therapeutics Recent Developments/Updates
    Table 23. CooperSurgical Fertility Basic Information, Manufacturing Base and Competitors
    Table 24. CooperSurgical Fertility Major Business
    Table 25. CooperSurgical Fertility Hyaluronidase Product and Services
    Table 26. CooperSurgical Fertility Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. CooperSurgical Fertility Recent Developments/Updates
    Table 28. Shreya Life Sciences Basic Information, Manufacturing Base and Competitors
    Table 29. Shreya Life Sciences Major Business
    Table 30. Shreya Life Sciences Hyaluronidase Product and Services
    Table 31. Shreya Life Sciences Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Shreya Life Sciences Recent Developments/Updates
    Table 33. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
    Table 34. Sun Pharmaceutical Industries Major Business
    Table 35. Sun Pharmaceutical Industries Hyaluronidase Product and Services
    Table 36. Sun Pharmaceutical Industries Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Sun Pharmaceutical Industries Recent Developments/Updates
    Table 38. CBC Pharma Basic Information, Manufacturing Base and Competitors
    Table 39. CBC Pharma Major Business
    Table 40. CBC Pharma Hyaluronidase Product and Services
    Table 41. CBC Pharma Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. CBC Pharma Recent Developments/Updates
    Table 43. STEMCELL Technologies Basic Information, Manufacturing Base and Competitors
    Table 44. STEMCELL Technologies Major Business
    Table 45. STEMCELL Technologies Hyaluronidase Product and Services
    Table 46. STEMCELL Technologies Hyaluronidase Sales Quantity (L), Average Price (USD/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. STEMCELL Technologies Recent Developments/Updates
    Table 48. Global Hyaluronidase Sales Quantity by Manufacturer (2018-2023) & (L)
    Table 49. Global Hyaluronidase Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 50. Global Hyaluronidase Average Price by Manufacturer (2018-2023) & (USD/mL)
    Table 51. Market Position of Manufacturers in Hyaluronidase, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 52. Head Office and Hyaluronidase Production Site of Key Manufacturer
    Table 53. Hyaluronidase Market: Company Product Type Footprint
    Table 54. Hyaluronidase Market: Company Product Application Footprint
    Table 55. Hyaluronidase New Market Entrants and Barriers to Market Entry
    Table 56. Hyaluronidase Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Hyaluronidase Sales Quantity by Region (2018-2023) & (L)
    Table 58. Global Hyaluronidase Sales Quantity by Region (2024-2029) & (L)
    Table 59. Global Hyaluronidase Consumption Value by Region (2018-2023) & (USD Million)
    Table 60. Global Hyaluronidase Consumption Value by Region (2024-2029) & (USD Million)
    Table 61. Global Hyaluronidase Average Price by Region (2018-2023) & (USD/mL)
    Table 62. Global Hyaluronidase Average Price by Region (2024-2029) & (USD/mL)
    Table 63. Global Hyaluronidase Sales Quantity by Type (2018-2023) & (L)
    Table 64. Global Hyaluronidase Sales Quantity by Type (2024-2029) & (L)
    Table 65. Global Hyaluronidase Consumption Value by Type (2018-2023) & (USD Million)
    Table 66. Global Hyaluronidase Consumption Value by Type (2024-2029) & (USD Million)
    Table 67. Global Hyaluronidase Average Price by Type (2018-2023) & (USD/mL)
    Table 68. Global Hyaluronidase Average Price by Type (2024-2029) & (USD/mL)
    Table 69. Global Hyaluronidase Sales Quantity by Application (2018-2023) & (L)
    Table 70. Global Hyaluronidase Sales Quantity by Application (2024-2029) & (L)
    Table 71. Global Hyaluronidase Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. Global Hyaluronidase Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. Global Hyaluronidase Average Price by Application (2018-2023) & (USD/mL)
    Table 74. Global Hyaluronidase Average Price by Application (2024-2029) & (USD/mL)
    Table 75. North America Hyaluronidase Sales Quantity by Type (2018-2023) & (L)
    Table 76. North America Hyaluronidase Sales Quantity by Type (2024-2029) & (L)
    Table 77. North America Hyaluronidase Sales Quantity by Application (2018-2023) & (L)
    Table 78. North America Hyaluronidase Sales Quantity by Application (2024-2029) & (L)
    Table 79. North America Hyaluronidase Sales Quantity by Country (2018-2023) & (L)
    Table 80. North America Hyaluronidase Sales Quantity by Country (2024-2029) & (L)
    Table 81. North America Hyaluronidase Consumption Value by Country (2018-2023) & (USD Million)
    Table 82. North America Hyaluronidase Consumption Value by Country (2024-2029) & (USD Million)
    Table 83. Europe Hyaluronidase Sales Quantity by Type (2018-2023) & (L)
    Table 84. Europe Hyaluronidase Sales Quantity by Type (2024-2029) & (L)
    Table 85. Europe Hyaluronidase Sales Quantity by Application (2018-2023) & (L)
    Table 86. Europe Hyaluronidase Sales Quantity by Application (2024-2029) & (L)
    Table 87. Europe Hyaluronidase Sales Quantity by Country (2018-2023) & (L)
    Table 88. Europe Hyaluronidase Sales Quantity by Country (2024-2029) & (L)
    Table 89. Europe Hyaluronidase Consumption Value by Country (2018-2023) & (USD Million)
    Table 90. Europe Hyaluronidase Consumption Value by Country (2024-2029) & (USD Million)
    Table 91. Asia-Pacific Hyaluronidase Sales Quantity by Type (2018-2023) & (L)
    Table 92. Asia-Pacific Hyaluronidase Sales Quantity by Type (2024-2029) & (L)
    Table 93. Asia-Pacific Hyaluronidase Sales Quantity by Application (2018-2023) & (L)
    Table 94. Asia-Pacific Hyaluronidase Sales Quantity by Application (2024-2029) & (L)
    Table 95. Asia-Pacific Hyaluronidase Sales Quantity by Region (2018-2023) & (L)
    Table 96. Asia-Pacific Hyaluronidase Sales Quantity by Region (2024-2029) & (L)
    Table 97. Asia-Pacific Hyaluronidase Consumption Value by Region (2018-2023) & (USD Million)
    Table 98. Asia-Pacific Hyaluronidase Consumption Value by Region (2024-2029) & (USD Million)
    Table 99. South America Hyaluronidase Sales Quantity by Type (2018-2023) & (L)
    Table 100. South America Hyaluronidase Sales Quantity by Type (2024-2029) & (L)
    Table 101. South America Hyaluronidase Sales Quantity by Application (2018-2023) & (L)
    Table 102. South America Hyaluronidase Sales Quantity by Application (2024-2029) & (L)
    Table 103. South America Hyaluronidase Sales Quantity by Country (2018-2023) & (L)
    Table 104. South America Hyaluronidase Sales Quantity by Country (2024-2029) & (L)
    Table 105. South America Hyaluronidase Consumption Value by Country (2018-2023) & (USD Million)
    Table 106. South America Hyaluronidase Consumption Value by Country (2024-2029) & (USD Million)
    Table 107. Middle East & Africa Hyaluronidase Sales Quantity by Type (2018-2023) & (L)
    Table 108. Middle East & Africa Hyaluronidase Sales Quantity by Type (2024-2029) & (L)
    Table 109. Middle East & Africa Hyaluronidase Sales Quantity by Application (2018-2023) & (L)
    Table 110. Middle East & Africa Hyaluronidase Sales Quantity by Application (2024-2029) & (L)
    Table 111. Middle East & Africa Hyaluronidase Sales Quantity by Region (2018-2023) & (L)
    Table 112. Middle East & Africa Hyaluronidase Sales Quantity by Region (2024-2029) & (L)
    Table 113. Middle East & Africa Hyaluronidase Consumption Value by Region (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Hyaluronidase Consumption Value by Region (2024-2029) & (USD Million)
    Table 115. Hyaluronidase Raw Material
    Table 116. Key Manufacturers of Hyaluronidase Raw Materials
    Table 117. Hyaluronidase Typical Distributors
    Table 118. Hyaluronidase Typical Customers
List of Figures
    Figure 1. Hyaluronidase Picture
    Figure 2. Global Hyaluronidase Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Hyaluronidase Consumption Value Market Share by Type in 2022
    Figure 4. Animal-derived Hyaluronidase Examples
    Figure 5. Synthetic Hyaluronidase Examples
    Figure 6. Global Hyaluronidase Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Hyaluronidase Consumption Value Market Share by Application in 2022
    Figure 8. Dermatology Examples
    Figure 9. Plastic Surgery Examples
    Figure 10. Global Hyaluronidase Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Hyaluronidase Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Hyaluronidase Sales Quantity (2018-2029) & (L)
    Figure 13. Global Hyaluronidase Average Price (2018-2029) & (USD/mL)
    Figure 14. Global Hyaluronidase Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Hyaluronidase Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Hyaluronidase by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Hyaluronidase Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Hyaluronidase Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Hyaluronidase Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Hyaluronidase Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Hyaluronidase Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Hyaluronidase Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Hyaluronidase Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Hyaluronidase Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Hyaluronidase Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Hyaluronidase Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Hyaluronidase Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Hyaluronidase Average Price by Type (2018-2029) & (USD/mL)
    Figure 29. Global Hyaluronidase Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Hyaluronidase Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Hyaluronidase Average Price by Application (2018-2029) & (USD/mL)
    Figure 32. North America Hyaluronidase Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Hyaluronidase Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Hyaluronidase Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Hyaluronidase Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Hyaluronidase Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Hyaluronidase Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Hyaluronidase Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Hyaluronidase Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Hyaluronidase Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Hyaluronidase Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Hyaluronidase Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Hyaluronidase Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Hyaluronidase Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Hyaluronidase Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Hyaluronidase Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Hyaluronidase Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Hyaluronidase Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Hyaluronidase Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Hyaluronidase Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Hyaluronidase Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Hyaluronidase Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Hyaluronidase Market Drivers
    Figure 73. Hyaluronidase Market Restraints
    Figure 74. Hyaluronidase Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Hyaluronidase in 2022
    Figure 77. Manufacturing Process Analysis of Hyaluronidase
    Figure 78. Hyaluronidase Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

PrimaPharm
Bausch Health
Amphastar Pharmaceuticals
Halozyme Therapeutics
CooperSurgical Fertility
Shreya Life Sciences
Sun Pharmaceutical Industries
CBC Pharma
STEMCELL Technologies

Related Reports

Global Hyaluronidase Supply, Demand and Key Producers, 2023-2029

Global Hyaluronidase Supply, Demand and Key Producers, 2023-2029

date 01 Mar 2023

date Pharma & Healthcare

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.

Global Hyaluronidase Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Hyaluronidase Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Hyaluronidase market size was valued at USD 823.8 million in 2023 and is forecast to a readjusted size of USD 1248.1 million by 2030 with a CAGR of 6.1% during review period.

Product Tags

Hyaluronidase Power Injection

Synthetic Hyaluronidase

Hyaluronidase

Hyaluronidase Injection

Recombinant Human Hyaluronidase PH20

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>